BrainSpace

BrainSpace is a medical technology company dedicated to automating neurocritical care and cerebrospinal fluid (CSF) management. Their primary product is an automated CSF management system that enables continuous intracranial pressure (ICP) monitoring and precise CSF drainage control. This system is designed to protect the brain after events like strokes, traumatic brain injuries, or surgeries, and assists in diagnosing treatable forms of dementia. The company's system features a wearable disposable device and a bedside console, which together facilitate continuous monitoring, automated drainage, patient movement tracking, and advanced analytics. BrainSpace aims to enhance patient safety, reduce ICU staff burnout, and lower healthcare costs. Their technology also contributes to building machine learning training data and expanding access to neurocritical care both in the US and globally. The founding team at BrainSpace has significant experience in the medical device industry, including work with startups and Fortune 500 companies. They are currently advancing their product through FDA 510(k) clearance and preparing for market launch after demonstrating a functional prototype to clinical experts and hospital administrators.

• Employees 15
• Total Funding $5229222